Study NO. | Prevalencea (95% CI) | Weight % | ||
---|---|---|---|---|
Diagnostic method | PCR | 10 | 0.06 (0.04–0.09) | 45.50 |
Serology | 8 | 0.23 (0.10–0.35) | 27.90 | |
Culture | 6 | 0.17 (0.10–0.24) | 26.60 | |
Total | 24 | 0.13 (0.11–0.24) | 100 | |
Study type | Case – control | 9 | 0.16 (0.11–0.21) | 36.67 |
Sectional | 15 | 0.13 (0.08–0.17) | 66.33 | |
Total | 24 | 0.13 (0.11–0.24) | 100 | |
Continent | Europe | 14 | 0.13 (0.09–0.18) | 59.55 |
Asia | 3 | 0.08 (−0.01–0.17) | 10.70 | |
USA | 6 | 0.15 (0.08–0.22) | 20.06 | |
Africa | 1 | 0.29 (0.23–0.34) | 3.69 | |
Total | 24 | 0.13 (0.11–0.24) | 100 | |
Recognize group | NO | 14 | 0.04 (0.02–0.05) | 57.08 |
Yes | 10 | 0.26 (0.19–0.33) | 42.92 | |
Total | 24 | 0.13 (0.11–0.24) | 100 |